Transforming bioengineering with unbiased teams and tools

por Jewell, Christopher M., Miljković, Miloš D., Oakes, Robert S.
Publicado 2023

Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer

por Waldmann, Thomas A., Miljkovic, Milos D., Conlon, Kevin C.
Publicado 2019

IL-15 in the Combination Immunotherapy of Cancer

por Waldmann, Thomas A., Dubois, Sigrid, Miljkovic, Milos D., Conlon, Kevin C.
Publicado 2020

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020

por Miljković, Miloš D., Tuia, Jordan E., Olivier, Timothée, Haslam, Alyson, Prasad, Vinay
Publicado 2022

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies

por Miljkovic, Milos D., Dubois, Sigrid P., Müller, Jürgen R., Bryant, Bonita, Ma, Elaine, Conlon, Kevin C., Waldmann, Thomas A.
Publicado 2022

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

por Miljkovic, Milos D., Melani, Christopher, Pittaluga, Stefania, Lakhotia, Rahul, Lucas, Nicole, Jacob, Allison, Yusko, Erik, Jaffe, Elaine S., Wilson, Wyndham H., Roschewski, Mark
Publicado 2021

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

por Daenthanasanmak, Anusara, Lin, Yuquan, Zhang, Meili, Bryant, Bonita R., Petrus, Michael N., Bamford, Richard N., Thomas, Craig J., Miljkovic, Milos D., Conlon, Kevin C., Waldmann, Thomas A.
Publicado 2020

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

por Dubois, Sigrid P, Miljkovic, Milos D, Fleisher, Thomas A, Pittaluga, Stefania, Hsu-Albert, Jennifer, Bryant, Bonita R, Petrus, Michael N, Perera, Liyanage P, Müller, Jürgen R, Shih, Joanna H, Waldmann, Thomas A, Conlon, Kevin C
Publicado 2021

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

por Daenthanasanmak, Anusara, Bamford, Richard N., Yoshioka, Makoto, Yang, Shyh-Ming, Homan, Philip, Karim, Baktiar, Bryant, Bonita R., Petrus, Michael N., Thomas, Craig J., Green, Patrick L., Miljkovic, Milos D., Conlon, Kevin C., Waldmann, Thomas A.
Publicado 2022

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

por Melani, Christopher, Advani, Ranjana, Roschewski, Mark, Walters, Kelsey M., Chen, Clara C., Baratto, Lucia, Ahlman, Mark A., Miljkovic, Milos D., Steinberg, Seth M., Lam, Jessica, Shovlin, Margaret, Dunleavy, Kieron, Pittaluga, Stefania, Jaffe, Elaine S., Wilson, Wyndham H.
Publicado 2018